INTERNATIONAL PATENT: THPHARM CORP., 주식회사 티에치팜 FILES APPLICATION FOR "PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING METABOLIC DYSFUNCTION-RELATED FATTY LIVER DISEASE COMPRISING EMPAGLIFLOZIN AND TELMISARTAN"

GENEVA, Dec. 16 -- THPHARM CORP. (3F, A-06, 194-25, Osongsaengmyeong 1-ro, Osong-eup, Heungdeok-gu,Cheongju-si,Chungcheongbuk-do 28160), 주식회사 티에치팜 (충청북도청주시흥덕구 오송읍 오송생명1로 194-25, 3층 에이-06) filed a patent application (PCT/KR2025/007568) for "PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING METABOLIC DYSFUNCTION-RELATED FATTY LIVER DISEASE COMPRISING EMPAGLIFLOZIN AND TELMISARTAN" on Jun 02, 2025. With publication no. WO/2025/254426, the details related to the patent application was published on Dec 11, 2025.

Notably, the patent applicati...